tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Teva Pharmaceutical Industries Ltd

TEVA
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
33.210USD
+1.010+3.14%
์ข…๊ฐ€ย 06/23, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
38.24B์‹œ๊ฐ€์ด์•ก
26.97P/E TTM

Teva Pharmaceutical Industries Ltd

33.210
+1.010+3.14%
์ƒ์„ธ ์ฐจํŠธ ๋ณด๊ธฐ
TradingKey ๅ›พ่กจ
Intraday
1m
30m
1h
D
W
M
D

์˜ค๋Š˜

+3.14%

5์ผ

+0.91%

1๊ฐœ์›”

-2.52%

6๊ฐœ์›”

+5.29%

์˜ฌํ•ด ํ˜„์žฌ๊นŒ์ง€

+6.41%

1๋…„

+95.70%

ํ•ต์‹ฌ ์ˆ˜์น˜
32.200์‹œ๊ฐ€
33.340์ตœ๊ณ ๊ฐ€
5.57M๊ฑฐ๋ž˜๋Ÿ‰
26.97P/E TTM
10.51๋™์  P/E ๋น„์œจ
--๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.48%ํšŒ์ „์œจ
32.200์ „์ผ ์ข…๊ฐ€
32.120์ตœ์ €๊ฐ€
111.20M๋งค์ถœ์•ก
์†์‹ค์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ
4.70P/B
0.00%๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
3.99%ROA
37.34552์ฃผ ์ตœ๊ณ ๊ฐ€
0.81๊ฑฐ๋ž˜๋Ÿ‰ ๋น„์œจ
-1.64B์ˆœ์ด์ต
1.16B์ฃผ์‹
1.2314์ฃผ๋‹น์ˆœ์ด์ต
0.84๋ฒ ํƒ€
21.60%ROE
14.99052์ฃผ ์ตœ์ €๊ฐ€
3.79%๋ณ€๋™ ํญ
49.36%์ด ์ด์ต๋ฅ 
38.24B์‹œ๊ฐ€์ด์•ก
-2.98๋ณด์ƒ/์œ„ํ—˜
1.84%์œ„ํ—˜๋ฅ 

TradingKey Teva Pharmaceutical Industries Ltd ์ฃผ์‹ ์ ์ˆ˜๎˜

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-06-23

์ฃผ์š” ์ธ์‚ฌ์ดํŠธ

Teva Pharmaceutical Industries Ltd์˜ ํŽ€๋”๋ฉ˜ํ„ธ์€ ๋น„๊ต์  ์•ˆ์ •์  ์ƒํƒœ์ด๋ฉฐ, ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์€ ๋†’์Šต๋‹ˆ๋‹ค.๊ธฐ์—…์˜ ๋ฐธ๋ฅ˜์—์ด์…˜์€ ์ ์ •ํ•˜๊ฒŒ ํ‰๊ฐ€๋œ ๊ฒƒ์œผ๋กœ ๊ฐ„์ฃผ๋˜๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—…์—์„œ 157๊ฐœ ์ค‘ 59์œ„ ๋žญํ‚น.๊ธฐ๊ด€ ๋ณด์œ  ๋น„์œจ์€ ๋งค์šฐ ๋†’์€.์ง€๋‚œ ํ•œ ๋‹ฌ ๋™์•ˆ ์—ฌ๋Ÿฌ ์• ๋„๋ฆฌ์ŠคํŠธ๊ฐ€ ํ•ด๋‹น ๊ธฐ์—…์„ ๋งค์ˆ˜(์œผ)๋กœ ํ‰๊ฐ€ํ–ˆ์œผ๋ฉฐ, ์ตœ๊ณ  ๋ชฉํ‘œ ๊ฐ€๊ฒฉ์€ 40.26์ž…๋‹ˆ๋‹ค.์ค‘๊ธฐ์ ์œผ๋กœ ์ฃผ๊ฐ€๋Š” ์ƒ์Šน ์ถ”์„ธ์ผ ๊ฒƒ์œผ๋กœ ์˜ˆ์ƒ๋ฉ๋‹ˆ๋‹ค.์ง€๋‚œ ํ•œ ๋‹ฌ๊ฐ„ ์ฃผ์‹ ์‹œ์žฅ์—์„œ ํ‰๋ฒ”ํ•œ ์„ฑ๊ณผ๋ฅผ ๊ฑฐ๋‘์—ˆ์ง€๋งŒ, ๊ธฐ์—…์˜ ํŽ€๋”๋ฉ˜ํ„ธ๊ณผ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๋Š” ํƒ„ํƒ„ํ•ฉ๋‹ˆ๋‹ค.์ฃผ๊ฐ€๋Š” ์ง€์ง€์„ ๊ณผ ์ €ํ•ญ์„  ์‚ฌ์ด์—์„œ ํšก๋ณดํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ๋ฒ”์œ„ ๋งค๋งค ๊ธฐ๋ฐ˜์˜ ์Šค์œ™ ํŠธ๋ ˆ์ด๋”ฉ์— ์ ํ•ฉํ•œ ์ƒํ™ฉ์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd ์ ์ˆ˜๎˜ฐ๎˜ฐ

๊ด€๋ จ ์ •๋ณด

์‚ฐ์—… ์ˆœ์œ„
59 / 157
์ „์ฒด ์ˆœ์œ„
125 / 4573
์‚ฐ์—…
์ œ์•ฝ

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

๋ ˆ์ด๋” ์ฐจํŠธ

ํ˜„์žฌ ๊ฐ€๊ฒฉ
๊ณผ๊ฑฐ

๋ฏธ๋””์–ด ๋ณด๋„

์ตœ๊ทผ 24 ์‹œ๊ฐ„
๋ณด๋„ ์ˆ˜์ค€

๋งค์šฐ ๋‚ฎ์€
๋งค์šฐ ๋†’์€
๋ถ€์ •-

Teva Pharmaceutical Industries Ltd ์ฃผ์š” ๋‚ด์šฉ

๊ฐ•์ ์œ„ํ—˜ ์š”์†Œ
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
์ด์ต ์ „ํ™˜
ํšŒ์‚ฌ์˜ ์‹ค์ ์ด ํ‘์ž๋กœ ์ „ํ™˜๋˜์–ด, ์ตœ๊ทผ ์—ฐ๊ฐ„ ์ˆœ์ด์ต์€ ๋ฏธํ™” ๋‹ฌ๋Ÿฌ์— ๋‹ฌํ•ฉ๋‹ˆ๋‹ค.
๊ณผ๋Œ€ ํ‰๊ฐ€๋œ
ํšŒ์‚ฌ์˜ ์ตœ์‹  PE์€ 26.97๋กœ, ์ตœ๊ทผ 3๋…„ ๊ธฐ์ค€ ๋†’์€ ๋ฐฑ๋ถ„์œ„ ๋ฒ”์œ„์— ์†ํ•ฉ๋‹ˆ๋‹ค.
๊ธฐ๊ด€ ๋งค์ˆ˜
์ตœ์‹  ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋Š” 725.07M์ฃผ์ด๋ฉฐ, ์ „ ๋ถ„๊ธฐ ๋Œ€๋น„ 1.25% ์ฆ๊ฐ€ํ–ˆ์Šต๋‹ˆ๋‹ค.
ํ”„๋ž€์‹œ์Šค์ฝ” ๊ฐ€๋ฅด์‹œ์•„ ํŒŒ๋ผ๋ฉ”์Šค๊ฐ€ ๋ณด์œ 
์Šคํƒ€ ํˆฌ์ž์ž ํ”„๋ž€์‹œ์Šค์ฝ” ๊ฐ€๋ฅด์‹œ์•„ ํŒŒ๋ผ๋ฉ”์Šค์ด(๊ฐ€) ์ด ์ฃผ์‹ 3.74M์ฃผ๋ฅผ ๋ณด์œ ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

๋ถ„์„๊ฐ€ ๋ชฉํ‘œ๊ฐ€

12 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
40.263
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+25.04%
์ƒ์Šน ์—ฌ๋ ฅ
๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd ๋‰ด์Šค

๋” ๋งŽ์€ ๋‰ด์Šค๊ฐ€ ๊ณง ์—…๋ฐ์ดํŠธ๋ฉ๋‹ˆ๋‹ค. ๊ณ„์† ์ง€์ผœ๋ด ์ฃผ์„ธ์š”โ€ฆ

์žฌ๋ฌด ์ง€ํ‘œ๎˜

EPS

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ด ์ˆ˜์ต

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd ์ •๋ณด๎˜

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
์ข…๋ชฉ ์ฝ”๋“œ TEVA
ํšŒ์‚ฌTeva Pharmaceutical Industries Ltd
CEOFrancis (Richard D)
์›น์‚ฌ์ดํŠธhttps://www.tevapharm.com/

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Teva Pharmaceutical Industries Ltd(TEVA)์˜ ํ˜„์žฌ ๊ฐ€๊ฒฉ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd(TEVA)์˜ ํ˜„์žฌ ์ฃผ๊ฐ€๋Š” 33.21์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ข…๋ชฉ ๊ธฐํ˜ธ(Symbol)๋Š” ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ ์ข…๋ชฉ ์ฝ”๋“œ๋Š” TEVA์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” 37.34์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” 14.99์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์‹œ๊ฐ€์ด์•ก์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ ์‹œ๊ฐ€์ด์•ก์€ 38.66B์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd(TEVA)์˜ ํ˜„์žฌ ํˆฌ์ž ๋“ฑ๊ธ‰์€ ๋งค์ˆ˜, ๋ณด์œ , ๋งค๋„ ์ค‘ ์–ด๋–ค๊ฐ€์š”?

๎™Œ
์• ๋„๋ฆฌ์ŠคํŠธ๋“ค์— ๋”ฐ๋ฅด๋ฉด, Teva Pharmaceutical Industries Ltd(TEVA)๋Š” ์ „๋ฐ˜์ ์ธ ํ‰๊ฐ€์—์„œ ๊ตฌ์ž…ํ•˜๋‹ค ๋“ฑ๊ธ‰์„ ๋ฐ›๊ณ  ์žˆ์œผ๋ฉฐ, ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” 40.26์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd(TEVA)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd(TEVA)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ 1.23์ž…๋‹ˆ๋‹ค.
KeyAI
๎™